Skip to content

How can you influence dementia research?

Are you interested in brain health and want to influence dementia research? If yes, please join the Public Involvement Pool, created by Alzheimer Europe (PREDICTOM parnter).

Public Involvement

Photo: Frida Ripland Moberg, Helse Stavanger

Published 12 February 2025

Contribute to Dementia Research with Alzheimer Europe

Become a part of European dementia research through Alzheimer Europe, a non-profit organisation committed to improving the lives of people affected by dementia. In 2023, Alzheimer Europe created the Public Involvement Pool (PI Pool), an online network that enables people from across Europe to influence dementia research meaningfully.

Join the PI Pool, an online network created for people from the general public to influence research by sharing their insight, experience and concerns with leading researchers. One of the key projects you can contribute to, through involvement in the PI Pool, is PREDICTOM, which focuses on the early detection and management of dementia.

 🔍 What to Expect:

  • Influence how research is conducted

  • Share your experience and insight with researchers through online surveys or meetings

  • Receive newsletters about news and events

  • Get feedback on how your contributions have been used by researchers

  • Participate as much or as little as you wish (minimum one contribution per year)

  • Opt out at any time, with your privacy protected by Alzheimer Europe’s General Privacy Policy

🔗 Sign up here

🔗 Learn more about the PI Pool

Join us today and share this post to spread the word!

Public Unvolvement Pool Flyer

Latest news

🧲 New MRI Technique to Speed Up Multi-Contrast MRI Scans and Advance Early Alzheimer’s Biomarker Discovery

News

🧲 New MRI Technique to Speed Up Multi-Contrast MRI Scans and Advance Early Alzheimer’s Biomarker Discovery

A new publication from PREDICTOM introduces a promising method to dramatically accelerate multi-contrast brain MRI scans, without sacrificing image quality. The technique could pave the way for earlier and more accessible diagnosis of neurodegenerative diseases like Alzheimer’s disease.

Read more
🧠 New Blood Test Clue in Alzheimer’s: Syndecan-3 Emerges as a Promising Biomarker

News

🧠 New Blood Test Clue in Alzheimer’s: Syndecan-3 Emerges as a Promising Biomarker

In a breakthrough that could reshape early detection of Alzheimer’s disease, researchers have identified a novel blood-based biomarker that may help distinguish Alzheimer’s patients from healthy individuals—potentially paving the way for simpler, less invasive diagnostics.

Read more
Over 50? Join the PREDICTOM Study and Help Advance Brain Health!

News

Over 50? Join the PREDICTOM Study and Help Advance Brain Health!

Would you like to help us understand how to reduce the risk of developing Alzheimer’s Disease?

Read more